A Phase IIa Cancer Prevention Trial of the PPAR Gamma Agonist Pioglitazone in Oral Leukoplakia
|Effective start/end date||9/30/01 → 9/29/07|
- NIH NATIONAL CANCER INSTITUTE (NCI)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.